Global Macular Degeneration Treatment Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 98

Report ID: 5378

Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. While it does not result in complete blindness, loss of central vision can make it hard to recognize faces, drive, read, or perform other activities of daily life. Visual hallucinations may also occur but these do not represent a mental illness.
In 2018, the global Macular Degeneration Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Macular Degeneration Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Macular Degeneration Treatment development in United States, Europe and China.

The key players covered in this study
Bausch Health Companies
Allergan
Novartis
Pfizer
Bayer
Roche
Sanofi
Santen Pharmaceuticals
Regeneron Pharmaceuticals
Kanghong Pharma

Market segment by Type, the product can be split into
Lucentis
Eylea
Avastin
Others

Market segment by Application, split into
Hospitals
Eye Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Macular Degeneration Treatment status, future forecast, growth opportunity, key market and key players.
To present the Macular Degeneration Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Macular Degeneration Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Macular Degeneration Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Lucentis
1.4.3 Eylea
1.4.4 Avastin
1.4.5 Others
1.5 Market by Application
1.5.1 Global Macular Degeneration Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Eye Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Macular Degeneration Treatment Market Size
2.2 Macular Degeneration Treatment Growth Trends by Regions
2.2.1 Macular Degeneration Treatment Market Size by Regions (2014-2025)
2.2.2 Macular Degeneration Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Macular Degeneration Treatment Market Size by Manufacturers
3.1.1 Global Macular Degeneration Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Macular Degeneration Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Macular Degeneration Treatment Key Players Head office and Area Served
3.3 Key Players Macular Degeneration Treatment Product/Solution/Service
3.4 Date of Enter into Macular Degeneration Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Macular Degeneration Treatment Market Size by Type (2014-2019)
4.2 Global Macular Degeneration Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Macular Degeneration Treatment Market Size (2014-2019)
5.2 Macular Degeneration Treatment Key Players in United States
5.3 United States Macular Degeneration Treatment Market Size by Type
5.4 United States Macular Degeneration Treatment Market Size by Application

6 Europe
6.1 Europe Macular Degeneration Treatment Market Size (2014-2019)
6.2 Macular Degeneration Treatment Key Players in Europe
6.3 Europe Macular Degeneration Treatment Market Size by Type
6.4 Europe Macular Degeneration Treatment Market Size by Application

7 China
7.1 China Macular Degeneration Treatment Market Size (2014-2019)
7.2 Macular Degeneration Treatment Key Players in China
7.3 China Macular Degeneration Treatment Market Size by Type
7.4 China Macular Degeneration Treatment Market Size by Application

8 Japan
8.1 Japan Macular Degeneration Treatment Market Size (2014-2019)
8.2 Macular Degeneration Treatment Key Players in Japan
8.3 Japan Macular Degeneration Treatment Market Size by Type
8.4 Japan Macular Degeneration Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Macular Degeneration Treatment Market Size (2014-2019)
9.2 Macular Degeneration Treatment Key Players in Southeast Asia
9.3 Southeast Asia Macular Degeneration Treatment Market Size by Type
9.4 Southeast Asia Macular Degeneration Treatment Market Size by Application

10 India
10.1 India Macular Degeneration Treatment Market Size (2014-2019)
10.2 Macular Degeneration Treatment Key Players in India
10.3 India Macular Degeneration Treatment Market Size by Type
10.4 India Macular Degeneration Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Macular Degeneration Treatment Market Size (2014-2019)
11.2 Macular Degeneration Treatment Key Players in Central & South America
11.3 Central & South America Macular Degeneration Treatment Market Size by Type
11.4 Central & South America Macular Degeneration Treatment Market Size by Application

12 International Players Profiles
12.1 Bausch Health Companies
12.1.1 Bausch Health Companies Company Details
12.1.2 Company Description and Business Overview
12.1.3 Macular Degeneration Treatment Introduction
12.1.4 Bausch Health Companies Revenue in Macular Degeneration Treatment Business (2014-2019)
12.1.5 Bausch Health Companies Recent Development
12.2 Allergan
12.2.1 Allergan Company Details
12.2.2 Company Description and Business Overview
12.2.3 Macular Degeneration Treatment Introduction
12.2.4 Allergan Revenue in Macular Degeneration Treatment Business (2014-2019)
12.2.5 Allergan Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Macular Degeneration Treatment Introduction
12.3.4 Novartis Revenue in Macular Degeneration Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Macular Degeneration Treatment Introduction
12.4.4 Pfizer Revenue in Macular Degeneration Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Bayer
12.5.1 Bayer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Macular Degeneration Treatment Introduction
12.5.4 Bayer Revenue in Macular Degeneration Treatment Business (2014-2019)
12.5.5 Bayer Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Macular Degeneration Treatment Introduction
12.6.4 Roche Revenue in Macular Degeneration Treatment Business (2014-2019)
12.6.5 Roche Recent Development
12.7 Sanofi
12.7.1 Sanofi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Macular Degeneration Treatment Introduction
12.7.4 Sanofi Revenue in Macular Degeneration Treatment Business (2014-2019)
12.7.5 Sanofi Recent Development
12.8 Santen Pharmaceuticals
12.8.1 Santen Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Macular Degeneration Treatment Introduction
12.8.4 Santen Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2014-2019)
12.8.5 Santen Pharmaceuticals Recent Development
12.9 Regeneron Pharmaceuticals
12.9.1 Regeneron Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Macular Degeneration Treatment Introduction
12.9.4 Regeneron Pharmaceuticals Revenue in Macular Degeneration Treatment Business (2014-2019)
12.9.5 Regeneron Pharmaceuticals Recent Development
12.10 Kanghong Pharma
12.10.1 Kanghong Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Macular Degeneration Treatment Introduction
12.10.4 Kanghong Pharma Revenue in Macular Degeneration Treatment Business (2014-2019)
12.10.5 Kanghong Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details